319 related articles for article (PubMed ID: 9503046)
21. Influence of daily calcium and vitamin D supplementation on parathyroid hormone secretion.
Reginster JY; Zegels B; Lejeune E; Micheletti MC; Taquet AN; Albert A
Gynecol Endocrinol; 2001 Feb; 15(1):56-62. PubMed ID: 11293926
[TBL] [Abstract][Full Text] [Related]
22. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S
Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
[TBL] [Abstract][Full Text] [Related]
23. The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD.
Kooienga L; Fried L; Scragg R; Kendrick J; Smits G; Chonchol M
Am J Kidney Dis; 2009 Mar; 53(3):408-16. PubMed ID: 19185400
[TBL] [Abstract][Full Text] [Related]
24. Vitamin D supplementation has minor effects on parathyroid hormone and bone turnover markers in vitamin D-deficient bedridden older patients.
Björkman M; Sorva A; Risteli J; Tilvis R
Age Ageing; 2008 Jan; 37(1):25-31. PubMed ID: 17965037
[TBL] [Abstract][Full Text] [Related]
25. Bone turnover and maternal 25(OH) vitamin D3 levels during pregnancy and the postpartum period: should routine vitamin D supplementation be increased in pregnant women?
Haliloglu B; Ilter E; Aksungar FB; Celik A; Coksuer H; Gunduz T; Yucel E; Ozekici U
Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):24-7. PubMed ID: 21543150
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D supplementation to healthy children does not affect serum osteocalcin or markers of type I collagen turnover.
Schou AJ; Heuck C; Wolthers OD
Acta Paediatr; 2003 Jul; 92(7):797-801. PubMed ID: 12892157
[TBL] [Abstract][Full Text] [Related]
27. Psoriasis and vitamin D3. A review of our experience.
Morimoto S; Yoshikawa K
Arch Dermatol; 1989 Feb; 125(2):231-4. PubMed ID: 2536537
[TBL] [Abstract][Full Text] [Related]
28. The photoproduction of 1 alpha,25-dihydroxyvitamin D3 in skin: an approach to the therapy of vitamin-D-resistant syndromes.
Holick MF; Uskokovic M; Henley JW; MacLaughlin J; Holick SA; Potts JT
N Engl J Med; 1980 Aug; 303(7):349-54. PubMed ID: 6248779
[TBL] [Abstract][Full Text] [Related]
29. [Vitamin D deficiency rickets: single-dose therapy versus continuous therapy].
Stögmann W; Sacher M; Blümel P; Woloszczuk W
Padiatr Padol; 1985; 20(4):385-92. PubMed ID: 3001619
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D insufficiency and treatment with oral vitamin D3 in children with chronic kidney disease.
Kari JA; Eldesoky SM; Bagdadi OT
Saudi Med J; 2012 Jul; 33(7):740-4. PubMed ID: 22821307
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D deficiency in kidney transplant recipients: risk factors and effects of vitamin D3 supplements.
Marcén R; Ponte B; Rodríguez-Mendiola N; Fernández-Rodriguez A; Galeano C; Villafruela JJ; Teruel JL; Burgos FJ; Ortuño J
Transplant Proc; 2009; 41(6):2388-90. PubMed ID: 19715928
[TBL] [Abstract][Full Text] [Related]
32. [Vitamin D supplementation in institutionalized elderly. Effects of vitamin D3 (100,000 IU) orally administered every 3 months on serum levels of 25-hydroxyvitamin D].
Zeghoud F; Jardel A; Garabedian M; Salvatore R; Moulias R
Rev Rhum Mal Osteoartic; 1990 Nov; 57(11):809-13. PubMed ID: 1963239
[TBL] [Abstract][Full Text] [Related]
33. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study.
Chandra P; Binongo JN; Ziegler TR; Schlanger LE; Wang W; Someren JT; Tangpricha V
Endocr Pract; 2008; 14(1):10-7. PubMed ID: 18238736
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of body weight-adapted oral cholecalciferol substitution in dialysis patients with vitamin D deficiency.
Zitt E; Sprenger-Mähr H; Mündle M; Lhotta K
BMC Nephrol; 2015 Aug; 16():128. PubMed ID: 26238347
[TBL] [Abstract][Full Text] [Related]
35. Follow-up study of biological parameters in elderly institutionalized patients more than one year after discontinuation of calcium-vitamin D supplementation.
Sebert JL; Fardellone P; Maamer M; Agbomson F; Brazier M; Garabedian M
Rev Rhum Engl Ed; 1996; 63(7-8):498-501. PubMed ID: 8896064
[TBL] [Abstract][Full Text] [Related]
36. Pathology of experimental vitamin D deficiency in turkeys and the effects of various vitamin D supplements.
Perry RW; Rowland GN; Britton WM
Avian Dis; 1991; 35(3):542-53. PubMed ID: 1659368
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of acute administration of 19-Nor-1,25-dihydroxy-vitamin D2 and 1,25-dihydroxy-vitamin D3 on serum calcium and phosphorus in hemodialysis patients.
Coyne DW; Grieff M; Ahya SN; Giles K; Norwood K; Slatopolsky E
Am J Kidney Dis; 2002 Dec; 40(6):1283-8. PubMed ID: 12460048
[TBL] [Abstract][Full Text] [Related]
38. Why dialysis patients need combination therapy with both cholecalciferol and a calcitriol analogs.
Jones G
Semin Dial; 2010; 23(3):239-43. PubMed ID: 20492584
[TBL] [Abstract][Full Text] [Related]
39. Cholecalciferol supplements improve vitamin D deficiency in renal transplant recipients.
Jiménez Álvaro S; Marcén R; Villacorta J; Fernández-Rodríguez A; Galeano C; Villafruela JJ; Teruel JL; Burgos FJ; Quereda C
Transplant Proc; 2010 Oct; 42(8):2921-3. PubMed ID: 20970571
[TBL] [Abstract][Full Text] [Related]
40. [Administration of a single Winter oral dose of 200,000 IU of vitamin D3 in adolescents in Normandy: evaluation of the safety and vitamin D status obtained].
Mallet E; Philippe F; Castanet M; Basuyau JP
Arch Pediatr; 2010 Jul; 17(7):1042-6. PubMed ID: 20542672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
